Josephson Neil 4
4 · Zymeworks Inc. · Filed Mar 11, 2022
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
Josephson Neil
Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2022-03-10−1,666→ 3,334 total→ Common Shares (1,666 underlying) - Exercise/Conversion
Common Shares
2022-03-10+729→ 7,848 total - Exercise/Conversion
Restricted Stock Unit
2022-03-10−729→ 730 total→ Common Shares (729 underlying) - Exercise/Conversion
Common Shares
2022-03-10+1,666→ 9,514 total
Footnotes (5)
- [F1]Represents common shares issued upon vesting of one third of the restricted stock units ("RSUs") granted on March 10, 2020.
- [F2]Represents common shares issued upon vesting of one third of the RSUs granted on March 10, 2021.
- [F3]Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F4]The RSUs were granted on March 10, 2020 and vest in three equal annual instalments beginning on March 10, 2021.
- [F5]The RSUs were granted on March 10, 2021 and vest in three equal annual instalments beginning on March 10, 2022.